# Kailera Therapeutics, Inc.: Form 8-K, filed Apr 20, 2026

- Company: [Kailera Therapeutics, Inc.](/companies/klra.md) (CIK 2096997)
- Form: 8-K
- Filed: 2026-04-20
- Accepted by EDGAR: Apr 20, 2026, 16:19 ET
- Period: 2026-04-20
- Accession: 0001193125-26-164040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2096997/000119312526164040/d137434d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2096997/000119312526164040/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2096997/000119312526164040/d137434d8k.htm

Filed Apr 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-164040. Last ingested by Listed: Nov 4, 2026, 17:09 ET. No prices; not investment advice.